Population analysis of xenobiotic metabolizing genes in South Brazilian Euro and Afro-descendants

Genetics and Molecular Biology

Volumn 32, Issue 4, 2009, Pages 723-728

  Maciel, Marcos Euzébio ^a   Oliveira, Fausto Koga ^a   Propst, Gustavo Bonfim ^a   Bicalho, Maria Da Graça ^a   Cavalli, Iglenir João ^a   Ribeiro, Enilze Maria De Souza Fonseca ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

CYP; GST; Population study

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; XENOBIOTIC AGENT;

ADULT; ARTICLE; BRAZIL; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MALE; MUTANT; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RACE; XENOBIOTIC METABOLISM;

EID: 73449095439     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572009005000087     Document Type: Article

References (55)

1. Abdel-Rahman SZ, El-Zein RA, Anwar WA and Au WW (1996) A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 107:229-233.
2. Adeyemo AA, Chen G, Chen Y and Rotimi C (2005) Genetic structure in four West African population groups. BMC Genet 6:38.
3. Amorim LM, Lotsch PF, Simão TDT de A, Gallo CV and Pinto LF (2004) Analysis of CYP1A1 exon 7 polymorphisms by PCR-SSCP in a Brazilian population and description of two novel gene variations. Mutat Res 547:35-40.
4. Ardlie KG, Lunetta KL and Seielstad M (2002) Testing for population subdivision and association in four case-control studies. Am J Hum Genet 71:304-311.
5. Arruda VR, Grignolli CE, Gonçalves MS, Soares MC, Menezes R, Saad STO and Costa FF (1998) Prevalence of homozygosity for the deleted alleles of glutatione S-transferase mu (GSTM1) and theta (GSTT1) among distinct ethnic groups from Brazil: Relevance to enviromental carcinogenesis? Clin Genet 54:210-214.
6. Autrup H (2000) Genetic polymorphisms in human xenobiotic metabolizing enzymes as suscetibility factors in toxic response. Mutat Res 464:65-76.
7. Bignon JD and Fernandez-Viña MA (1997) Protocols of the 12th Internacional Histocompatibility Workshop for typing of HLA class II alleles by DNA amplification by the polymerase chain reaction (PCR) and hybridization with sequence specific oligonucleotide probes (SSOP). In: Charron D (ed) HLA. Genetic Diversity of HLA: Functional and Medical Implications. Proceedings of the 12th International Histocompatibility Workshop and Conference, v. 1. EDK, Paris, pp 584-595.
8. Carstensen U, Alexandrie AK, Högstedt B, Rannug A, Bratt I and Hagmar L (1993) Band T- lymphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GSTM1 (Class Mu). Mutat Res 289:187-195.
9. Dandara C, Sayi J, Masimirembwa CM, Magimba A, Kaaya S, De Sommers K, Snyman JR and Hasler JA (2002) Genetic polymorphism of cytochrome P450 1A1 (CYP1A1) and glutathione transferases (M1, T1 and P1) among Africans. Clin Chem Lab Med 40:952-957.
10. Dufour C, Svahn J, Bacigalupo A, Longoni D, Varotto S, Iori AP, Bagnasco F, Locasciulli A, Menna G, U Ramenghi, et al. (2005) Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anemia in Caucasian patients. Haematologica 90:1027-1031.
11. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Pookot D, Li LC, Tabatabai ZL, Kawahara M, Nakagawa M, et al. (2005) Ethnic grouprelated differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer 116:174-181.
12. Excoffier L, Smouse PE and Quattro JM (1992) Analysis of molecular variance inferred from metric distances among DNA haplotypes: Application to human mitochondrial DNA restriction data. Genetics 131:592-608.
13. Ford JG, Li Y, O'Sullivan MM, Demopoulos R, Garte S, Taioli E and Brandt-Rauf PW (2000) Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis 21:1971-1975.
14. Freedman ML, Reich D, Penney KL, Mcdonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, et al. (2004) Assessing the impact of population stratification on genetic association studies. Nat Genet 36:388-393.
15. Gaedigk A, Bradford LD, Marcucci KA and Leeder JS (2002) Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans. Clin Pharmacol Ther 72:76-89.
16. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W and Szyfter Z (2005) CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 574:112-123.
17. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, et al. (2001) Metabolic gene polymorphisms frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10:1239-1248.
18. Gaspar PA, Kvitko K, Papadopolis LG, HutzMHand Weimer TA (2002) High frequency of CYP1A1*2C allele in Brazilian populations. Hum Biol 74:235-242.
19. Gattás GJF and Soares-Vieira JA (2000) Cytochrome P450-2E1 and glutathione S-transferase mu polymorphisms among Caucasians and Mulattoes from Brazil. Occup Med 50:508-511.
20. Gattás GJF, Kato M, Soares-Vieira JA, Siraque MS, Kohler P, Gomes L, Rego MAV and Bydlowski SP (2004) Ethnicity and glutathione S-transferase (GSTM1/GSTT1) polymorphisms in a Brazilian population. Braz J Med Biol Res 34:451-458.
21. Geisler SA and Olshan AF (2001) GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: A mini-huge review. Am J Epidemiol 154:95-103.
22. Gudmundsdottir K, Tryggvadottir L and Eyfjord JE (2001) GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene. Can Epidemiol Biom Prev 10:1169-1173.
23. Harries LW, Stubbins MJ, Forman D, Howard GC and Wolf CR (1997) Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with suscetibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641-644.
24. Hatagima A, Marques CF, Krieger H and Feitosa MF (2004) Glutatione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms in a Brazilian mixed population. Hum Biol 76:937-942.
25. Huang CS, Shen CY, Chang KJ, Hsu SM and Chern HD (1999) Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Br J Cancer 80:1838-1843.
26. Hung RJ, Boffetta P, Brockmöller J, Butkiewicz D, Cascorbi I, Clapper ML, Garte S, Haugen A, Hirvonen A, Anttila S, et al. (2003) CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: A pooled analysis, Carcinogenesis 24:875-882.
27. Kato S, Shields PG, Caporaso NE, Sugimura H, Trivers GE, Tucker MA, Trump BF, Weston A and Harris CC (1992) Cytochrome P450IIEI genetic polymorphisms racial variation and lung cancer risk. Cancer Res 56:6712-6715.
28. Kittles RA and Weiss KM (2003) Race, ancestry, and genes: Implications for defining disease risk. Annu Rev Genomics Hum Genet 4:33-67.
29. Kvitko K, Gaspar PA, Torres AR and Hutz M (2006) CYP1A1, GSTM1, GSTT1 and GSTP1 polymorphisms in an Afrobrazilian group. Genet Mol Biol 29:613-616.
30. Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR and Lau AF (1998) Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 58:4858-4863.
31. Leathart JB, London SJ, Steward A, Adams JD, Idle JR and Daly AK (1998) CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles. Pharmacogenetics 8:529-541.
32. Leichsenring A, Losi-Guembarovski R, Maciel ME, Losi-Guembarovski A, Oliveira BW, Ramos G, Cavalcanti TCS, Bicalho MG, Cavalli IJ, Cólus IMS, et al. (2006) CYP1A1 and GSTP1 polymorphisms in an oral cancer case-control study. Braz J Med Biol Res 39:1569-1574.
33. Longuemaux S, Deloménie C, Gallou C, Méjean A, Vincent-Viry M, Bouvier R, Droz D, Krishnamoorthy R, Galteau M, Junien C, et al. (1999) Candidate genetic modifiers of individual susceptibility to renal cell carcinoma:a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res 59:2903-2908.
34. Losi-Guembarovski R, D'arce LPG and Cóllus IMS (2002) Glutathione S-transferase mu (GSTM1) null genotype in relation to gender, age and smoking status in a healthy Brazilian population. Genet Mol Biol 25:357-360.
35. Losi-Guembarovski R, Cóllus IMS, De Menezes RP, Poliseli F, Chaves VN, Kuasne H, Leichsenring A, Guembarovski AL, Oliveira BW, Ramos G, et al. (2008) Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population. Anticancer Res 28:1023-1028.
36. Menoyo A, Del Rio E and Baiget M (2006) Characterization of variant alleles of cytochrome CYP2D6 in a Spanish population. Cell Biochem Funct 24:381-385.
37. Millikan R, Pittman G, Tse CK, Savitz DA, Newman B and BellD (2000) Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev 9:567-573.
38. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma V, Benhamou S, Vainio H, UusitupaMand Hirvonen A (2001) Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev 10:229-236.
39. Olshan AF, Weissler MC, Watson MA and Bell DA (2000) GSTM1, GSTT1, GSTP1,CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 9:185-191.
40. Park SK, Yoo KY, Lee SJ, Kim SU, Ahn SH, Noh DY, Choe KJ, Strickland PT, Hirvonen A and Kang D (2000) Alcohol comsumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics 10:301-309.
41. Raimondi S, Boffetta P, Anttila S, Bröckmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dragani TA, Garte S, Gsur A, et al. (2005) Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. Mutat Res 59:45-57.
42. Rossini A, Rapozo DCM, Amorim LMF, Macedo JMB, Medina R, Neto JFN, GalloCVMand Pinto LFR (2002) Frequencies of GSTM1, GSTT1 and GSTP1 polymorphisms in a Brazilian population. Genet Mol Res 1:233-240.
43. Rossini A, Soares-Lima S, Rapozo DCM, Faria M, Albano RM and Ribeiro-Pinto LF (2006) CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro. Braz J Med Biol Res 39:195-201.
44. Scordo MG, Caputi AP, D'arrigo C, Fava G and Spina E (2004) Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. Pharmacol Res 50:195-200.
45. Sobtia RC, Al-Badrana AI, Sharmaa S, Sharmab SK, Krishanc A and Mohand H (2005) Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 156:68-73.
46. Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dolzan V, Haugen A, et al. (2003) Polymorphisms in CYP1A1, GSTM1, GSTT1and lung cancer below the age of 45 years. Int J Epidemiol 32:60-63.
47. Torresan C, Oliveira MMC, Torrezan GT, Oliveira SFV, Abuázar CS, Losi-Guembarovski R, Lima RS, Urban CA, Cavalli IJ and Ribeiro EMSF (2008) Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: A positive association with combined CYP/GST genotypes. Clin Exp Med 8:65-71.
48. Varela-Lema L, Taioli E, Ruano-Ravina A, Barros-Dios JM, Anantharaman D, Boccia S, Bhisey RA, Cadoni G, Capoluongo E, Chen CJ, et al. (2008). Meta- and pooled analysis of GSTM1 and CYP1A1 polymorphisms and oral and pharyngeal cancers: A HuGE-GSEC review. Genet Med 10:369-384.
49. Wan YJ, Poland RE, Han G, Konishi T, Zheng YP, Berman N and Lin KM (2001) Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in Southern California. Pharmacogenetics 11:489-499.
50. Wenzlaff AS, Cote ML, Bock CH, Land SJ, Santer SK, Schwartz DR and Schwartz AG (2005) CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: A population-based study. Carcinogenesis 26:2207-2212.
51. Wrensch MR, Miike R, Sison JD, Kelsey KT, Liu M, McMillan A, Quesenberry C and Wiencke JK (2005) CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latins and African Americans. Int J Cancer 113:7-141.
52. Wu X, Shi H, Jiang H, Kemp B, Hong WK, Delclos GL and Spitz MR (1997) Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and suscetibility to lung cancer. Carcinogenesis 18:967-973.
53. Yang CX, Matsuo K, Wang ZM and Tajima K (2005) Phase I/II enzyme gene polymorphisms and esophageal cancer risk: A meta-analysis of the literature. World J Gastroenterol 11:2531-2538.
54. Zembrzuski VM, Callegari-Jacques SM and HutzMH(2006) Application of an African Ancestry Index as a genomic control approach in a Brazilian population. Ann Hum Genet 70:822-828.
55. Ziv E and Burchard EG (2003) Human population structure and genetic association studies. Pharmacogenomics 4:431-441.